A recent study led by Professor Zhao Lichun（赵立春）from the Research Center of Trace Elements and Health Development at Guizhou University of Traditional Chinese Medicine was published in the World Journal of Integrated traditional and western Medicine (WJIM), entitled “Theoretical Framework and Hypothesis on the Association Between Rubidium Ion Metabolic Dysregulation and Parkinson’s Disease.” This work, grounded in ionic homeostasis imbalance as a fundamental biophysical process, proposes an integrated theoretical model spanning “ion regulation-cellular dysfunction-neurodegeneration,” thereby providing a novel interpretative dimension and potential intervention perspective for the pathogenesis of Parkinson’s disease (PD).
Parkinson’s disease is a prototypical progressive neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra, abnormal aggregation of α-synuclein, and a cascade of neuroinflammatory responses. However, most existing studies have focused on single-layer mechanisms such as protein misfolding, oxidative stress, or mitochondrial dysfunction, with limited systematic integration of upstream regulatory factors, particularly the role of inorganic ion homeostasis. In this context, rubidium (Rb⁺), a long-neglected alkali metal element, has increasingly attracted attention for its potential regulatory roles in the nervous system.
Based on the strong chemical similarity between Rb⁺ and K⁺, the proposed theoretical framework suggests that Rb⁺ may competitively interfere with Na⁺/K⁺-ATPase activity and potassium ion channels, thereby disrupting neuronal membrane potential stability and excitatory–inhibitory balance, ultimately inducing electrophysiological network dysfunction. On this basis, even subtle perturbations in ionic homeostasis may be amplified into organelle-level dysfunction, particularly manifested as mitochondrial membrane potential depolarization, reduced electron transport chain efficiency, and excessive accumulation of reactive oxygen species (ROS). This process not only exacerbates oxidative stress but may also disrupt protein folding and degradation systems, thereby creating a permissive microenvironment for α-synuclein aggregation.
Further integrative analyses suggest that rubidium metabolic dysregulation may be closely associated with alterations in the neuroimmune microenvironment. In PD animal models, abnormal fluctuations in Rb⁺ levels are significantly correlated with sustained microglial activation, accompanied by increased pro-inflammatory cytokine release and aggravated dopaminergic neuronal injury. These findings indicate that Rb⁺ may not only participate in intrinsic neuronal metabolic regulation but may also contribute to neuroinflammatory cascade amplification via an “ion–inflammation axis,” thereby driving disease progression from functional disturbance to structural neurodegeneration.
Based on this multi-level evidence integration, this study constructs a stepwise pathological cascade framework—“rubidium metabolic dysregulation–ionic homeostasis imbalance–mitochondrial dysfunction–protein aggregation–neuroinflammatory activation”—systematically elucidating the potential role of Rb⁺ in PD pathogenesis. This framework extends beyond traditional “protein toxicity” and “oxidative stress” paradigms and provides a novel entry point for understanding the systems biology basis of neurodegenerative diseases.
Importantly, this hypothesis proposes that Rb⁺ may serve as a potential disease-related biomarker, with peripheral or central homeostatic alterations reflecting early pathological initiation in PD. Moreover, targeting Rb⁺ homeostasis to restore Na⁺/K⁺-dependent electrophysiological balance may offer a promising strategy for early intervention in Parkinson’s disease.
Overall, this study re-examines the pathogenesis of Parkinson’s disease from the perspective of ion biology, emphasizing the fundamental role of inorganic ion homeostasis in neurodegenerative disorders, and laying a theoretical foundation for future rubidium metabolomics research and targeted therapeutic development.
https://doi.org/10.70976/j.2096-0964.WJIM-2025-0048
World Journal of Integrated traditional and western Medicine (English Version) (WJIM, CN 10-1354/R, ISSN 2096-0964) is a quarterly, English-language, peer-reviewed academic journal dedicated to advancing the integration of traditional Chinese and Western medicine. Established in 2015, the journal is supervised by the China Association for Science and Technology and is solely sponsored by the China Association of Chinese Medicine. The founding Editor-in-Chief was Professor Wu Yiling, Academician of the Chinese Academy of Engineering, with Professor Lu Zhizheng, a distinguished TCM Master, serving as the Honorary Editor-in-Chief. The current Editor-in-Chief is Professor Zhang Xiaoxiao.
WJIM aims to report original theoretical research, the development and application of novel technologies and methodologies, as well as breakthroughs in clinical scientific inquiries, to promote the international exchange of Chinese medicine and integrative medicine.
WJIM welcomes manuscripts from all over the world on all aspects of traditional Chinese medicine, Chinese materia medica, and integrated traditional Chinese and Western medicine. Article types include Perspective, Review, Research Article, and Case Reports etc.
World Journal of Integrated Traditional and Western Medicine
10.70976/j.2096-0964.WJIM-2025-0048
Data/statistical analysis
Not applicable
Theoretical framework and hypothesis on the association between Rubidium Ion metabolic dysregulation and Parkinson’s Disease
16-Apr-2026